Premium accounts now available! Sign up and create a premium account. Read more Close

Advertisement

Image

The enigmatic bone reduction pattern of thalidomide embryopathy is set by sequential exit from the sensitive window

Preprint Created on 14 Sep 2026 bioRxiv

Thalidomide reduces the limb bones in a puzzling order, starting with the thumb, the radius and the humerus and then returning to the ulna and the ulnar digits. To understand that order we analysed 435 thalidomide-affected limbs from the published record (1962-2025), of which 269 were upper limbs - 142 human and 127 non-human primate. Reconstructed by forward-chain assembly the reduction order runs: Digit 1 [->] Radius [->] Humerus [->] Digit 2 [->] Ulna [->] Digit 3 [->] Digit 4 [->] Digit 5. The co-reductions resolved into two rules. Within a segment (autopod, zeugopod), no bone is reduced before every bone anterior to it. Among the most posterior bones of the three segments (digit 5, ulna, humerus): no bone is reduced before every bone proximal to it. Behind these antero-posterior (A-P) and proximo-distal (P-D) reduction rules stands a maturation wave advancing postero-anteriorly and disto-proximally. In developmental terms the bone precursors exit their sensitive windows after the autopod is built, in a biaxial order: from digit 5 towards digit 1, from the ulna to radius, and across segments from the autopod towards the stylopod (Digit 5 [->] Digit 4 [->] Digit 3 [->] Ulna [->] Digit 2 [->] Humerus [->] Radius [->] Digit 1). A co-reduction is therefore a snapshot of the prospective bones still sharing a sensitive window before their sequential biaxial maturation: exposure during elongation truncates the limb proximal to the progress zone, while later exposure reduces only the bones still immature at the time of exposure.

Cohen, Y.

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement